<DOC>
	<DOC>NCT02184065</DOC>
	<brief_summary>Observational study to evaluate the efficacy and safety of meloxicam (MobicoxÂ®) in Mexican population with rheumatic diseases</brief_summary>
	<brief_title>Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases</brief_title>
	<detailed_description />
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Age of 12 or older and rheumatologic disease Hypersensitivity to meloxicam Hypersensitivity to other Nonsteroidal antiinflammatory drugs (NSAIDS) History of asthma, angioedema or urticaria secondary to NSAIDS Pregnancy or lactation Recent or current history of peptic ulcer disease, severe renal failure and severe hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>